RCE in Nec Corporation Univerge Ix
CVE-2024-11013
Command Injection vulnerability in NEC Corporation UNIVERGE IX from Ver9.2 to Ver10.10.21, for Ver10.8 up to Ver10.8.27, for Ver10.9 up to Ver10.9.14 and UNIVERGE IX-R/IX-V Ver1.2.15 and earlier allows a attacker to inject an arbitrary CLI commands to be executed on the device via the management interface.
Vulnerability class: Command Injection (OS Command Injection)
Published · last modified .
CVSS v3 metric
CVSS v3 base score 7.2 (High). Vector: CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:H/I:H/A:H.
EPSS exploit prediction
EPSS: 0.011 (64.5th percentile), scored .
Low probability of exploitation in the next 30 days, but still tracked. 64th percentile — 64.5% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.
EPSS over last 30 days · oldest: 0.011 · newest: 0.011 · change: +0.000
Affected products
- Nec Corporation Univerge Ix — versions from Ver9.2 to Ver10.10.21, for Ver10.8 up to Ver10.8.27, for Ver10.9 up to Ver10.9.14
- Nec Corporation Univerge Ix-R/ix-V — versions Ver1.2.15 and earlier
Weakness classification (CWE)
References
Frequently asked questions
- What is CVE-2024-11013?
- CVE-2024-11013 is a high-severity vulnerability in Nec Corporation Univerge Ix, classified under Command Injection. CVSS score: 7.2/10. Published 2024-11-29.
- How severe is CVE-2024-11013?
- High severity. CVSS v3 base score is 7.2 out of 10.